Cost Effectiveness of Intensive Lowering of Ldl Cholesterol with Pcsk9 Inhibitors as an Adjunct to High-Intensity Statin Therapy for Prevention of Major Vascular Events

May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.118
https://www.valueinhealthjournal.com/article/S1098-3015(16)00186-8/fulltext
Section Title : Cardiovascular Disorders - Cost Studies
Section Order : 1449
First Page : A48
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00186-8&doi=10.1016/j.jval.2016.03.118
HEOR Topics :
Tags :
Regions :